Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic

Irene Fiorilla1,2, Simona Martinotti1,2, Alberto Maria Todesco1,2

  • 1Department of Science and Technological Innovation (DISIT), University of Eastern Piedmont, 15121 Alessandria, Italy.

Cells
|August 26, 2023
PubMed

Insights

Malignant pleural mesothelioma (MPM) is a rare cancer linked to asbestos. This review explores how chronic inflammation, oxidative stress, and metabolic changes in the tumor microenvironment drive MPM progression and offer new therapeutic targets.

Area of Science:

  • Oncology
  • Immunology
  • Environmental Health

Background:

  • Malignant pleural mesothelioma (MPM) is a rare, aggressive cancer primarily caused by asbestos exposure.
  • Asbestos induces chronic inflammation, oxidative stress (ROS generation), and aberrant signaling, leading to mesothelial cell transformation.
  • The tumor microenvironment, including hypoxia and immune cell interactions, significantly influences MPM aggressiveness.

Purpose of the Study:

  • To review the complex tumor-host interactions within the MPM microenvironment.
  • To elucidate the roles of soluble factors, metabolic crosstalk, and oxidative stress in MPM development and progression.
  • To identify potential novel therapeutic targets within the MPM tumor microenvironment.

Main Methods:

  • Literature review of studies on MPM pathogenesis and tumor microenvironment.
  • Analysis of mechanisms including chronic inflammation, oxidative stress, and metabolic reprogramming.
  • Examination of immune cell roles and signaling pathways in MPM.

Main Results:

  • Asbestos exposure triggers "frustrated" macrophages, releasing pro-inflammatory mediators and ROS, fueling chronic inflammation.
  • Hypoxia in the MPM microenvironment alters tumor and immune cell metabolism and plasticity, enhancing aggressiveness.
  • Complex interactions involving soluble factors, metabolic crosstalk, and oxidative stress are key drivers of MPM.

Conclusions:

  • The MPM tumor microenvironment presents a complex interplay of inflammatory, oxidative, and metabolic factors.
  • Understanding these intricate host-tumor interactions is crucial for developing effective therapeutic strategies.
  • Targeting specific components of the tumor microenvironment, such as oxidative stress and metabolic pathways, holds promise for novel MPM treatments.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
47
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.2K